Oxford’s Ebola vaccine recommended by WHO for use against Uganda outbreak
A new Ebola virus vaccine developed by the Oxford Vaccine Group is one of three vaccines recommended for a trial in Uganda to combat...
Oxford begins human trials for ebola vaccine
This vaccine is also unique in being multivalent - targeting multiple variants of the virus. By being able to target both Zaire and Sudan variants, the vaccine can be used in virtually all outbreaks and therefore governments can stockpile it, secure that it will be useful if a new outbreak appears.
Lessons Learned & Forgotten: The Role of Community During the Ebola Outbreak
The headspace flooding by
Covid-19, is a familiar experience for many communities torn by humanitarian
crises. The number of Covid-19 related fatalities has become almost arbitrary;
the...
